PYC Therapeutics在2025年初进入首个人体试验时,达到了52周高点,作为肾病药物候选者。 PYC Therapeutics(ASX:PYC)在周三创下52周新高,此前该公司宣布将在2025年初进入针对肾病药物候选物PYC-003的首次人体试验。 MT Newswires11/27 11:05 PYC Therapeutics表示安全审查委员会批准眼疾病研究中将剂量逐步增加至最终患者组...
Asia FX Rates Futures Crypto RangeDropdown Markets Asia Dow4,295.7671.841.70% Nikkei 22539,149.43-312.04-0.79% Hang Seng22,620.33805.963.69% Shanghai3,346.7214.240.43% Sensex75,939.21-199.76-0.26% Singapore3,877.50-5.08-0.13% Latest NewsAll Times Eastern ...
PYC Therapeutics通过权利发行筹集近14600万澳元 PYC Therapeutics(ASX:PYC)计划通过一种基于持有每四股股份可获得一新股的按比例加速不可撤回配股提议,最多筹集14600万澳元。 MT Newswires54分钟前 PYC Therapeutics 被Barrenjoey评为增持。 PYC治疗公司被评级为超重。 道琼斯02/14 04:58· 评级/大行评级 PYC Therapeu...
PYC Therapeutics, a biotechnology company combining two complementary platform technologies to develop a new generation of RNA therapeutics to change the lives of patients with inherited diseases, announced two upcoming virtual poster...
News provided by PYC Therapeutics Mar 29, 2021, 07:00 ET Share this article NEW YORKandPERTH, Australia,March 29, 2021/PRNewswire/ -- PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives...
PYC Therapeutics Limited (PYC) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
ACB News《澳华财经在线》8月21日讯,临床阶段 生物科技 公司PYC Therapeutics (ASX股票代码:PYC)获得澳洲医疗用品管理局(TGA)批准,将在本季度启动新药候选物PYC-001人体试验,旨在研究该药物在治疗罕见且致盲眼病——常染色体显性视神经萎缩(ADOA)的安全性和有效性
ACB News《澳华财经在线》7月24日讯,生物科技公司PYCTherapeuticsLtd(ASX股票代码:PYC)获得美国机构审查委员会(IRB)批准,可以扩大针对11型色素性视网膜炎(RP11)试验药物的研究范围。该进展预示PYC在美国FDA的新药上市申请再进一程。 周二PYC澳交所股价应声劲涨4.76%,报0.11澳元,成交量303万股。过去一年该股涨幅达...
Dianthus Therapeutics, Inc. 0.00% NQVWSCN $0.00 NASDAQ Victory US Small Cap 500 Volatility Weighted Index Net Total Return 0.00% PLCKF $0.00 Plurilock Security Inc. 0.00% VWVNX $0.00 WI Tomorrow's Scholar 529 Plan Voya 529 Age 16 Option C ...
Asia FX Rates Futures Crypto RangeDropdown Markets1D5D1M3M6M1Y2Y Asia Dow4,315.88-9.36-0.22% Nikkei 22539,244.6370.380.18% Hang Seng22,616.23-4.10-0.02% Shanghai3,355.839.110.27% Sensex75,996.8657.650.08% Singapore3,904.8527.350.71%